Cellectar Biosciences Inc.
CLRB | NASDAQ
$2.34
-$0.01 (-0.43%)
Sep 22, 2026, 9:35 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 213.6K | n/a | n/a | n/a | n/a | n/a |
Gross Profit | -213.6K | n/a | n/a | n/a | n/a | n/a |
Operating Income | -22.98M | -51.78M | -38.96M | -28.81M | -24.13M | -15.29M |
Interest Income | 435.1K | 1.21M | 387.15K | 152.52K | 2.28K | 10.9K |
Pretax Income | -21.79M | -44.52M | -42.83M | -31.85M | -24.12M | -15.09M |
Net Income | -21.79M | -44.58M | -42.77M | -31.79M | -24.12M | -15.09M |
Selling & General & Admin | 11.48M | 25.64M | 11.69M | 9.59M | 6.54M | 5.15M |
Research & Development | 11.5M | 26.14M | 27.27M | 19.22M | 17.59M | 10.14M |
Other Expenses | -213.6K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 22.77M | 51.78M | 38.96M | 28.81M | 24.13M | 15.29M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 22.98M | 51.78M | 38.96M | 28.81M | 24.13M | 15.29M |
Income Tax Expense | n/a | 66K | -60K | -60K | n/a | n/a |
Shares Outstanding (Basic) | 2.61M | 1.22M | 407.39K | 235.19K | 185.05K | 66.04K |
Shares Outstanding (Diluted) | 2.61M | 1.24M | 407.39K | 235.19K | 185.05K | 66.04K |
EPS (Basic) | -8.35 | -36.52 | -104.99 | -135.18 | -130.35 | -228.55 |
EPS (Diluted) | -8.35 | -41.89 | -104.99 | -135.18 | -130.35 | -228.55 |
EBITDA | -21.58M | -44.22M | -42.64M | -31.7M | -23.97M | -14.89M |
EBIT | -21.79M | -44.52M | -42.83M | -31.85M | -24.12M | -15.09M |
Depreciation & Amortization | 213.6K | 291.65K | 192.38K | 148.44K | 149.92K | 207.93K |
Add to Watchlist
Select watchlists to add or remove CLRB